Abstract
Retinitis pigmentosa (RP) is a group of inherited retinal disorders characterized by the progressive photoreceptors and pigment epithelial cells dysfunction. It is the most common retinal degeneration, responsible for loss of vision of most people worldwide. Until now its exact pathogenesis and etiology are not clear. So far there is no approved therapy. New approaches for RP therapy include cell transplantation, gene therapy, cytokine therapy, nutrition therapy, and hyperbaric oxygen therapy. Such therapies for retinal degenerative diseases are limited in their efficacy. This paper reviews the relevant documents, especially recent researches, and reviews advances in the treatment of RP.
Keywords: Cell transplantation, cytokine therapy, gene therapy, hyperbaric oxygen therapy, nutrition therapy, retinitis pigmentosa.
Current Stem Cell Research & Therapy
Title:Recent Advances in Treatment of Retinitis Pigmentosa
Volume: 10 Issue: 3
Author(s): Yuxi He, Yan Zhang and Guanfang Su
Affiliation:
Keywords: Cell transplantation, cytokine therapy, gene therapy, hyperbaric oxygen therapy, nutrition therapy, retinitis pigmentosa.
Abstract: Retinitis pigmentosa (RP) is a group of inherited retinal disorders characterized by the progressive photoreceptors and pigment epithelial cells dysfunction. It is the most common retinal degeneration, responsible for loss of vision of most people worldwide. Until now its exact pathogenesis and etiology are not clear. So far there is no approved therapy. New approaches for RP therapy include cell transplantation, gene therapy, cytokine therapy, nutrition therapy, and hyperbaric oxygen therapy. Such therapies for retinal degenerative diseases are limited in their efficacy. This paper reviews the relevant documents, especially recent researches, and reviews advances in the treatment of RP.
Export Options
About this article
Cite this article as:
He Yuxi, Zhang Yan and Su Guanfang, Recent Advances in Treatment of Retinitis Pigmentosa, Current Stem Cell Research & Therapy 2015; 10 (3) . https://dx.doi.org/10.2174/1574888X09666141027103552
DOI https://dx.doi.org/10.2174/1574888X09666141027103552 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Association of Fractalkine Receptor (T280M) Polymorphism in the Pathogenesis of Acute Coronary Syndrome in the Egyptian Population
Current Pharmaceutical Biotechnology Antisense Technology: A Selective Tool for Gene Expression Regulation and Gene Targeting
Current Pharmaceutical Biotechnology Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core
Current Topics in Medicinal Chemistry Nanoparticle Targeting to Inflamed Tissues of the Gastrointestinal Tract
Current Drug Delivery In Vitro Evaluation of Bioadhesive Films Containing Ibuprofen
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Fullerenes for Cancer Diagnosis and Therapy: Preparation, Biological and Clinical Perspectives
Current Drug Metabolism The Roles of Phosphodiesterase 2 in the Central Nervous and Peripheral Systems
Current Pharmaceutical Design Metabolomic Approach in Probing Drug Candidates
Current Topics in Medicinal Chemistry Pyrazole Derivatives as Antitumor, Anti-Inflammatory and Antibacterial Agents
Mini-Reviews in Medicinal Chemistry SUMOylation Modulates CFTR Biogenesis: Is the Pathway Druggable?
Current Drug Targets Therapeutic Strategy of Erythropoietin in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Heparan Sulphate Proteoglycans and Viral Vectors : Ally or Foe?
Current Gene Therapy Biomarkers for Alzheimer’s Disease
Current Alzheimer Research Impact of Immunogenetic Polymorphisms in Bone Marrow Failure Syndromes
Mini-Reviews in Medicinal Chemistry Pathophysiology of Idiopathic Atrial Fibrillation - Prognostic and Treatment Implications
Current Pharmaceutical Design Soluble Epoxide Hydrolase, a Target with Multiple Opportunities for Cardiovascular Drug Discovery
Current Topics in Medicinal Chemistry Cyclosporin A: A Therapeutic Strategy in Allergic Diseases
Letters in Drug Design & Discovery Review of Evidence and Perspectives of Flavonoids on Metabolic Syndrome and Neurodegenerative Disease
Protein & Peptide Letters Interleukin-6 and Malondialdehyde in Women with Preterm Birth
Current Immunology Reviews (Discontinued) Pleiotropic Beneficial Effects of Epigallocatechin Gallate, Quercetin and Delphinidin on Cardiovascular Diseases Associated with Endothelial Dysfunction
Cardiovascular & Hematological Agents in Medicinal Chemistry